What are the HLH‑2004 diagnostic criteria for hemophagocytic lymphohistiocytosis (HLH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HLH-2004 Diagnostic Criteria

The diagnosis of hemophagocytic lymphohistiocytosis requires either molecular confirmation of HLH-associated genetic mutations OR fulfillment of 5 out of 8 clinical and laboratory criteria. 1, 2

The 8 HLH-2004 Criteria (5 of 8 Required)

  1. Fever – Persistent high temperature 1, 2

  2. Splenomegaly – Enlarged spleen on physical examination or imaging 1, 2

  3. Cytopenias (≥2 of 3 lineages) 1, 2

    • Hemoglobin < 90 g/L (< 100 g/L in infants < 4 weeks)
    • Platelets < 100 × 10⁹/L
    • Neutrophils < 1.0 × 10⁹/L
  4. Hypertriglyceridemia and/or Hypofibrinogenemia 1, 2

    • Fasting triglycerides ≥ 3.0 mmol/L (≥ 265 mg/dL) OR
    • Fibrinogen ≤ 1.5 g/L
  5. Hemophagocytosis – Evidence in bone marrow, spleen, or lymph nodes without malignancy 1, 2

  6. Low or absent NK-cell activity – According to local laboratory reference 1, 2

  7. Ferritin ≥ 500 µg/L 1, 2

  8. Soluble CD25 (sIL-2 receptor) ≥ 2400 U/mL 1, 2

Critical Diagnostic Considerations

Start Treatment on Strong Clinical Suspicion

Do not delay HLH-directed therapy while waiting to fulfill all 5 criteria if clinical suspicion is high, as untreated HLH carries extremely high mortality. 2, 3 Treatment may be initiated with fewer than 5 criteria when the overall clinical picture is compelling. 2

Most Valuable Diagnostic Markers in Adults

  • Soluble CD25 (sCD25) is superior to ferritin for adult HLH diagnosis, with an area under the ROC curve of 0.90 (95% CI 0.83–0.97) versus ferritin's 0.78 (95% CI 0.67–0.88). 1, 4 This marker should be obtained in all patients with suspected HLH. 2, 4

  • Ferritin levels in adult HLH typically range 7,000–10,000 µg/L and can exceed 100,000 µg/L, far higher than the diagnostic threshold of 500 µg/L. 2 Rapidly rising ferritin indicates active disease. 3

  • Fever (98.96%), elevated ferritin (94.27%), elevated sCD25 (94.79%), and low/absent NK-cell activity (94.27%) are the most sensitive criteria, while hemophagocytosis (74.48%), hypofibrinogenemia (50.52%), and hypertriglyceridemia (37.50%) are less consistently present. 5

Hemophagocytosis Is Neither Sensitive Nor Specific

Absence of hemophagocytosis on initial bone marrow aspirate does NOT exclude HLH. 1, 3 Serial marrow aspirates or examination of other tissues (spleen, lymph nodes, liver) should be pursued if suspicion persists, as hemophagocytosis often appears later in the disease course. 1, 2

Alternative Scoring System: HScore (for Adults)

In critically ill adults, an HScore ≥ 168 provides 100% sensitivity and 94.1% specificity, slightly outperforming the HLH-2004 criteria. 6 The HScore incorporates 9 weighted parameters: 1

  • Known underlying immunosuppression (HIV or long-term immunosuppressive therapy)
  • Temperature (< 38.4°C, 38.4–39.4°C, or > 39.4°C)
  • Organomegaly (none, hepatomegaly or splenomegaly, or both)
  • Number of cytopenias (1,2, or 3 lineages; defined as Hgb ≤ 9.2 g/dL, WBC ≤ 5 × 10⁹/L, or PLT ≤ 110 × 10⁹/L)
  • Ferritin (< 2000–6000, or > 6000 µg/L)
  • Triglycerides (< 1.5,1.5–4, or > 4 mmol/L)
  • Fibrinogen (> 2.5 or ≤ 2.5 g/L)
  • AST (< 30 or ≥ 30 U/L)
  • Hemophagocytosis on bone marrow aspirate (yes/no)

Validation Limitations and Clinical Judgment

The HLH-2004 criteria were developed for pediatric patients and have never been formally validated in adults, yet they remain the standard diagnostic framework. 1, 2, 7 Various adult case series have used modified criteria. 1 Clinical judgment is essential when applying these criteria to adults, particularly in critically ill patients where HLH can mimic sepsis or multiple organ dysfunction syndrome. 3, 8

For critically ill adults, consider lowering the diagnostic threshold to 4 fulfilled HLH-2004 criteria (95.0% sensitivity, 93.6% specificity), or adjust cutoffs to ferritin ≥ 3000 µg/L and fever ≥ 38.2°C (97.5% sensitivity, 96.1% specificity). 6

Supportive Findings (Not Part of Formal Criteria)

Additional findings that strengthen the diagnosis include: 1, 3

  • Spinal fluid pleocytosis or elevated CSF protein
  • Liver histology resembling chronic persistent hepatitis
  • Cerebromeningeal symptoms, lymphadenopathy, jaundice, edema, skin rash
  • Hepatic enzyme abnormalities (present in 94.27% of cases) 5
  • Hypoproteinemia, hyponatremia
  • Elevated VLDL/low HDL
  • Coagulopathy (present in 75.52% of cases) 5

Mandatory Trigger Identification

In adults, nearly half of HLH cases are triggered by malignancy, with the proportion rising to 68% in patients > 60 years (35% T-cell/NK-cell lymphomas, 32% B-cell lymphomas). 2 In younger adults (30–59 years), malignancy accounts for 38% of cases. 3 Infection (especially EBV and CMV) is the second most common trigger. 2, 5

Mandatory screening includes: 3

  • Peripheral blood and bone marrow evaluation for blasts
  • Chest X-ray
  • CT or ultrasound of abdomen and enlarged lymph nodes
  • Biopsy of suspicious lymph nodes or cutaneous lesions

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

HLH Diagnostic Criteria and Practical Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hemophagocytic Lymphohistiocytosis Diagnosis and Clinical Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Soluble CD25 (sCD25) in the Diagnosis and Management of Adult Hemophagocytic Lymphohistiocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Clinical characteristics of 192 adult hemophagocytic lymphohistiocytosis].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014

Research

Diagnostic Challenges of Hemophagocytic Lymphohistiocytosis.

Clinical lymphoma, myeloma & leukemia, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.